ClassID:

95252

C07D403/12 - page 8 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2101
20200039931
2020-02-06

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#2102
20200038373
2020-02-06

Nuclear transport modulators and uses thereof

#2103
20200031838
2020-01-30

Process for making beta 3 agonists and intermediates

#2104
20200031805
2020-01-30

ARYL HYDROCARBON RECEPTOR (AHR) MODULATOR COMPOUNDS

#2105
20200031804
2020-01-30

Solid forms of cerdulatinib

#2106
20200031803
2020-01-30

Arylation method

#2107
20200031798
2020-01-30

BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF

#2108
20200031783
2020-01-30

Drugs and compositions for the treatment of ocular disorders

#2109
20200031781
2020-01-30

Compounds and their use as PDE4 activators

#2110
20200031770
2020-01-30

MEK INHIBITORS AND METHODS OF THEIR USE

#2111
20200024268
2020-01-23

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#2112
20200024266
2020-01-23

Inhibitors of cyclin-dependent kinases

#2113
20200024260
2020-01-23

Substituted reverse pyrimidine Bmi-1 inhibitors

#2114
20200024236
2020-01-23

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

#2115
20200017523
2020-01-16

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#2116
20200017481
2020-01-16

Hydantoin containing deoxyuridine triphosphatase inhibitors

#2117
20200017479
2020-01-16

NOVEL 5-ACYLSULFANYL-HISTIDINE COMPOUNDS AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THEIR DISULFIDES

#2118
20200017478
2020-01-16

Compounds and their use for reducing uric acid levels

#2119
20200017477
2020-01-16

Compounds and their use for reducing uric acid levels

#2120
20200017464
2020-01-16

Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone

#2121
20200017453
2020-01-16

Dimeric contrast agents

#2122
20200017452
2020-01-16

Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors

#2123
20200017448
2020-01-16

Cannabinoid receptor modulators

#2124
20200017442
2020-01-16

TETRACYCLIC COMPOUND

#2125
20200016141
2020-01-16

Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

#2126
20200010455
2020-01-09

Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

#2127
20200010427
2020-01-09

Substituted pyrimidines for treating bacterial infections

#2128
20200010426
2020-01-09

Amino pyrimidine derivatives

#2129
20200010421
2020-01-09

Pharmaceutically active compounds

#2130
20200010415
2020-01-09

Urea derivative or pharmacologically acceptable salt thereof

#2131
20200009129
2020-01-09

ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS

#2132
20200008425
2020-01-09

FUNGICIDAL PYRAZOLES

#2133
20200002326
2020-01-02

Sulfoximine glycosidase inhibitors

#2134
20200002317
2020-01-02

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

#2135
20200002310
2020-01-02

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#2136
20200002309
2020-01-02

Heterocyclic compounds useful as Pim kinase inhibitors

#2137
20200002295
2020-01-02

Aminopyrazine derivatives as PI3K-γ inhibitors

#2138
20200002279
2020-01-02

Inhibitors of EGFR and methods of use thereof

#2139
20200000802
2020-01-02

Phthalazinone derivatives

#2140
20200000774
2020-01-02

CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY

#2141
20190390172
2019-12-26

Agent for removing undifferentiated iPS cells

#2142
20190389844
2019-12-26

2-arylsulfonamido-N-arylacetamide derivatized STAT3 inhibitors

#2143
20190389842
2019-12-26

Process for the preparation of bazedoxifene

#2144
20190389815
2019-12-26

Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#2145
20190389812
2019-12-26

Inhibition of OLIG2 activity

#2146
20190389811
2019-12-26

Pyrimidines and variants thereof, and uses therefor

#2147
20190389796
2019-12-26

Covalent inhibitors of KRas G12C

#2148
20190388415
2019-12-26

Substituted dihydrobenzofuran glycosidase inhibitors

#2149
20190382407
2019-12-19

3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#2150
20190382385
2019-12-19

Tetrazolinone compounds and its use as pest control agents

#2151
20190382380
2019-12-19

Carboxamide compounds and uses thereof

#2152
20190382379
2019-12-19

Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors

#2153
20190381197
2019-12-19

Radiotracer derivatives of trimethoprim for diagnostic imaging

#2154
20190381053
2019-12-19

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

#2155
20190381042
2019-12-19

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#2156
20190381037
2019-12-19

Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#2157
20190381010
2019-12-19

Pyrazole derivatives as bromodomain inhibitors

#2158
20190380339
2019-12-19

Germination promoters

#2159
20190375730
2019-12-12

MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT

#2160
20190375726
2019-12-12

Compounds for the treatment of HIV

#2161
20190375718
2019-12-12

3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

#2162
20190375708
2019-12-12

Hepatitis B capsid assembly modulators

#2163
20190375704
2019-12-12

Modulators of the eIF2alpha pathway

#2164
20190374541
2019-12-12

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#2165
20190367533
2019-12-05

Glycosidase inhibitors

#2166
20190367521
2019-12-05

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#2167
20190367500
2019-12-05

Quinazoline derivative

#2168
20190367489
2019-12-05

Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

#2169
20190367488
2019-12-05

Benzodiazepine derivatives and uses thereof

#2170
20190367485
2019-12-05

Heteroaromatic compounds and their use as dopamine D1 ligands

#2171
20190367460
2019-12-05

Heterocyclic compounds as pesticides

#2172
20190367459
2019-12-05

Heterocyclic compounds as pesticides

#2173
20190367456
2019-12-05

BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE

#2174
20190367452
2019-12-05

MASP-2 inhibitors and methods of use

#2175
20190359620
2019-11-28

Heteroaryl SYK inhibitors

#2176
20190359599
2019-11-28

Compounds useful for treating gastrointestinal tract disorders

#2177
20190359597
2019-11-28

PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

#2178
20190359593
2019-11-28

Amide compounds and method for making and using

#2179
20190359591
2019-11-28

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

#2180
20190359578
2019-11-28

TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME

#2181
20190359577
2019-11-28

[4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF

#2182
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

#2183
20190358248
2019-11-28

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

#2184
20190358228
2019-11-28

2,4-pyrimidinediamine compounds and their uses

#2185
20190358226
2019-11-28

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#2186
20190355910
2019-11-21

Anthracene derivative, light emitting element using the same, and light emitting device using the same

#2187
20190352284
2019-11-21

Methyllactam ring compound and pharmaceutical use thereof

#2188
20190352276
2019-11-21

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2189
20190352268
2019-11-21

CANNABINOID RECEPTOR MEDIATING COMPOUNDS

#2190
20190346454
2019-11-14

Reagents and methods for analysis of proteins and metabolites targeted by covalent probes

#2191
20190345143
2019-11-14

Heparanase inhibitors and use thereof

#2192
20190345142
2019-11-14

Dimeric contrast agents

#2193
20190345109
2019-11-14

Therapeutic compounds and compositions

#2194
20190345099
2019-11-14

Nitric oxide donors

#2195
20190343797
2019-11-14

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#2196
20190338433
2019-11-07

SnAg alloy plating solution

#2197
20190337954
2019-11-07

Viral replication inhibitors

#2198
20190337931
2019-11-07

Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

#2199
20190337930
2019-11-07

Synthesis of cerdulatinib

#2200
20190337929
2019-11-07

Indolinones compounds and their use in the treatment of fibrotic diseases

#2201
20190330239
2019-10-31

Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2

#2202
20190330233
2019-10-31

Benzopiperazine compositions as BET bromodomain inhibitors

#2203
20190330202
2019-10-31

Compounds

#2204
20190330189
2019-10-31

ANTIBACTERIAL COMPOUNDS

#2205
20190330164
2019-10-31

Hydrazide containing nuclear transport modulators and uses thereof

#2206
20190330160
2019-10-31

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

#2207
20190330152
2019-10-31

FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT

#2208
20190330148
2019-10-31

Plant growth regulator compounds

#2209
20190328735
2019-10-31

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

#2210
20190322681
2019-10-24

Biotin derivatives

#2211
20190322668
2019-10-24

ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#2212
20190322660
2019-10-24

SMYD INHIBITORS

#2213
20190322656
2019-10-24

Compound, and production method thereof, and methods of treatment using the compound

#2214
20190322644
2019-10-24

Heterocyclic apelin receptor (APJ) agonists and uses thereof

#2215
20190322628
2019-10-24

HIV replication inhibiting pyrimidines

#2216
20190322627
2019-10-24

Agricultural chemicals

#2217
20190322626
2019-10-24

Human plasma kallikrein inhibitors

#2218
20190322624
2019-10-24

1-cyano-pyrrolidine compounds as USP30 inhibitors

#2219
20190321366
2019-10-24

Modulators of toll-like receptors

#2220
20190321345
2019-10-24

GLUT4 Selective Inhibitors for Cancer Therapy

#2221
20190315726
2019-10-17

Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activities

#2222
20190315724
2019-10-17

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

#2223
20190315723
2019-10-17

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

#2224
20190315722
2019-10-17

Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same

#2225
20190315721
2019-10-17

Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same

#2226
20190315714
2019-10-17

GSK-3 inhibitors

#2227
20190315693
2019-10-17

Apelin receptor (APJ) agonists and uses thereof

#2228
20190315688
2019-10-17

Inhibitors of tryptophan 2,3-dioxygenase

#2229
20190315687
2019-10-17

Substituted Pyrrolidines and Methods of Use

#2230
20190315675
2019-10-17

Aromatic amine derivatives, preparation methods therefor, and uses thereof

#2231
20190314372
2019-10-17

Substituted pyrimidines containing acidic groups as TLR7 modulators

#2232
20190308983
2019-10-10

HIV inhibitor compounds

#2233
20190308965
2019-10-10

Heteroaryl amides as inhibitors of protein aggregation

#2234
20190308955
2019-10-10

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

#2235
20190308954
2019-10-10

Process for purification of pyrazolpyridazines

#2236
20190308953
2019-10-10

Rho kinase inhibitors

#2237
20190308951
2019-10-10

Substituted Pyrazole Derivatives As Selective CDK12/13 Inhibitors

#2238
20190308949
2019-10-10

Quinoxaline compounds as type III receptor tyrosine kinase inhibitors

#2239
20190308942
2019-10-10

Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

#2240
20190307767
2019-10-10

Substituted quinazolines for inhibiting kinase activity

#2241
20190307747
2019-10-10

Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition

#2242
20190300514
2019-10-03

Dopamine Dreceptor antagonist compounds

#2243
20190300499
2019-10-03

Small molecule modulators of pantothenate kinases

#2244
20190300491
2019-10-03

Salt of quinazoline derivative, preparation method therefor and application thereof

#2245
20190298705
2019-10-03

Chemical Compounds

#2246
20190292435
2019-09-26

Method for sealing a void in a well using a smart gel sealant

#2247
20190292157
2019-09-26

NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME

#2248
20190292148
2019-09-26

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use

#2249
20190290654
2019-09-26

Substituted quinoxaline DNA-PK inhibitors

#2250
20190290648
2019-09-26

Cycloalkyl substituted triazole compounds as agonists of the APJ receptor

#2251
20190290647
2019-09-26

Alkyl substituted triazole compounds as agonists of the APJ Receptor

#2252
20190290632
2019-09-26

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#2253
20190284207
2019-09-19

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

#2254
20190284173
2019-09-19

Triazole phenyl compounds as agonists of the APJ receptor

#2255
20190284144
2019-09-19

Substituted quinazoline compounds and methods of use thereof

#2256
20190284138
2019-09-19

1-cyano-pyrrolidine compounds as USP30 inhibitors

#2257
20190282548
2019-09-19

Triazolone compounds as mPGES-1 inhibitors

#2258
20190276439
2019-09-12

METHOD OF TREATING SOLID TUMORS

#2259
20190276438
2019-09-12

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

#2260
20190276398
2019-09-12

N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

#2261
20190275008
2019-09-12

Triazole furan compounds as agonists of the APJ receptor

#2262
20190274954
2019-09-12

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid

#2263
20190270759
2019-09-05

Heteroaryl inhibitors of PDE4

#2264
20190270751
2019-09-05

Bicyclic-fused heteroaryl or aryl compounds

#2265
20190270732
2019-09-05

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

#2266
20190270730
2019-09-05

6-substituted quinazolinone inhibitors

#2267
20190270713
2019-09-05

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#2268
20190270708
2019-09-05

1-cyano-pyrrolidine compounds as USP30 inhibitors

#2269
20190270704
2019-09-05

Phenylpyrrolidinone formyl peptide 2 receptor agonists

#2270
20190269683
2019-09-05

Modulators of cystic fibrosis transmembrane conductance regulator

#2271
20190269650
2019-09-05

Somatostatin receptor subtype 4 (SSTR4) agonists

#2272
20190269134
2019-09-05

Substituted sulfonyl amides for controlling animal pests

#2273
20190263787
2019-08-29

C-anilinoquinazoline compounds and their use in treating cancer

#2274
20190263786
2019-08-29

Therapeutic compounds and methods of use thereof

#2275
20190263779
2019-08-29

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

#2276
20190263758
2019-08-29

ACSS2 inhibitors and methods of use thereof

#2277
20190263757
2019-08-29

3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#2278
20190262866
2019-08-29

Method and apparatus for sorting heterogeneous material

#2279
20190262356
2019-08-29

Heterocyclic amides as kinase inhibitors

#2280
20190262324
2019-08-29

Pyridine and Pyrazine Derivative for the Treatment of CF

#2281
20190256520
2019-08-22

Indazole compounds and uses thereof

#2282
20190256513
2019-08-22

Azole amides and amines as alpha v integrin inhibitors

#2283
20190256504
2019-08-22

Cardiac sarcomere inhibitors

#2284
20190256503
2019-08-22

LLS compounds for treatment of cancer

#2285
20190256500
2019-08-22

Indazole compounds and uses thereof

#2286
20190256493
2019-08-22

Diphenylaminopyrimidine and triazine compound, and pharmaceutical composition and use thereof

#2287
20190256476
2019-08-22

Compositions and methods for inhibition of the JAK pathway

#2288
20190256475
2019-08-22

Kinase inhibitors for the treatment of disease

#2289
20190255062
2019-08-22

DNA-PK inhibitors

#2290
20190255047
2019-08-22

2,4-pyrimidinediamine compounds and their uses

#2291
20190248806
2019-08-15

ULK1 inhibitors and methods using same

#2292
20190248805
2019-08-15

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#2293
20190248791
2019-08-15

NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER

#2294
20190248766
2019-08-15

Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same

#2295
20190248761
2019-08-15

Non-selective kinase inhibitors

#2296
20190248760
2019-08-15

Indole carboxamide compounds

#2297
20190241588
2019-08-08

Tricyclic sulfones as RORγ modulators

#2298
20190241574
2019-08-08

Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same

#2299
20190241555
2019-08-08

Pyrimidine compound as JAK kinase inhibitor

#2300
20190241546
2019-08-08

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

#2301
20190241523
2019-08-08

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#2302
20190241514
2019-08-08

Elimination of hepatitis B virus with antiviral agents

#2303
20190240220
2019-08-08

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#2304
20190240213
2019-08-08

Nitrogen-containing heteroaryl compounds and methods of use thereof

#2305
20190233440
2019-08-01

Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents

#2306
20190233408
2019-08-01

Indole derivatives as estrogen receptor degraders

#2307
20190233402
2019-08-01

Compounds

#2308
20190233401
2019-08-01

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

#2309
20190233400
2019-08-01

Crystalline form of Olaparib

#2310
20190225597
2019-07-25

Pyrrolidine derivatives as PPAR agonists

#2311
20190225587
2019-07-25

INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES

#2312
20190225583
2019-07-25

Carbazole derivatives

#2313
20190225575
2019-07-25

Antiviral compounds

#2314
20190218204
2019-07-18

Biaryl inhibitors of Bruton'S tyrosine kinase

#2315
20190216812
2019-07-18

Therapeutic compounds and uses thereof

#2316
20190216810
2019-07-18

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#2317
20190216774
2019-07-18

TRPV4 antagonists

#2318
20190210998
2019-07-11

Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof

#2319
20190210995
2019-07-11

QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

#2320
20190210977
2019-07-11

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

#2321
20190209572
2019-07-11

BIFUNCTIONAL ANTIFUNGAL AGENTS AND METHODS OF TREATING FUNGAL INFECTION

#2322
20190209564
2019-07-11

Inhibitors of fibroblast growth factor receptor and use thereof

#2323
20190202811
2019-07-04

Aminoacylindazole immunomodulators for treatment of autoimmune diseases

#2324
20190202803
2019-07-04

6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME

#2325
20190202790
2019-07-04

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#2326
20190202782
2019-07-04

Compounds and uses thereof for the modulation of hemoglobin

#2327
20190201413
2019-07-04

Heterocyclic amides as kinase inhibitors

#2328
20190194184
2019-06-27

Benzenesulfonamide compounds and their use as therapeutic agents

#2329
20190194174
2019-06-27

Quinazolinones as PARP14 inhibitors

#2330
20190194173
2019-06-27

6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists

#2331
20190194172
2019-06-27

PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS

#2332
20190194170
2019-06-27

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

#2333
20190194165
2019-06-27

Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor

#2334
20190194162
2019-06-27

Inhibitors of lysine specific demethylase-1

#2335
20190194161
2019-06-27

Inhibitor of lysine specific demethylase-1

#2336
20190194148
2019-06-27

TETRAZOLE-CONTAINING 1,2-CYCLOPROPANE-CARBOXAMIDES

#2337
20190194147
2019-06-27

toxin inhibitors

#2338
20190194145
2019-06-27

Amino quinazolines as kinase inhibitors

#2339
20190194144
2019-06-27

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#2340
20190194141
2019-06-27

Process for preparing pyrazoles

#2341
20190192535
2019-06-27

Combination pharmaceutical agents as RSV inhibitors

#2342
20190192515
2019-06-27

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors

#2343
20190192512
2019-06-27

2,4-disubstituted pyrimidines useful as kinase inhibitors

#2344
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2345
20190185458
2019-06-20

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors

#2346
20190185451
2019-06-20

Inhibitors of fibroblast activation protein

#2347
20190185436
2019-06-20

Triazoles for the treatment of demyelinating dieases

#2348
20190185426
2019-06-20

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

#2349
20190183123
2019-06-20

3-pyridyloxyphenyldihydrouracil compound and use thereof

#2350
20190177311
2019-06-13

Pharmacokinetically improved compounds

#2351
20190177300
2019-06-13

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

#2352
20190177272
2019-06-13

2-pyrrolidine phenylhydrazides antibacterial agents

#2353
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#2354
20190175606
2019-06-13

Biaryl amide compounds as kinase inhibitors

#2355
20190169166
2019-06-06

Heterocyclic compound

#2356
20190169165
2019-06-06

Benzazepine compounds, conjugates, and uses thereof

#2357
20190169164
2019-06-06

Benzazepine compounds, conjugates, and uses thereof

#2358
20190169158
2019-06-06

Small molecule activators of Parkin enzyme function

#2359
20190169132
2019-06-06

Methods of forming carbene-functionalized composite materials

#2360
20190169127
2019-06-06

Tubulin inhibitors

#2361
20190167636
2019-06-06

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#2362
20190161476
2019-05-30

Pyrimidine derivative, method for preparing same and use thereof in medicine

#2363
20190161445
2019-05-30

Urea derivative or pharmacologically acceptable salt thereof

#2364
20190161437
2019-05-30

PENDANT AMINES AND DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#2365
20190160063
2019-05-30

Nuclear transport modulators and uses thereof

#2366
20190160046
2019-05-30

Modulators of calcium release-activated calcium channel

#2367
20190152991
2019-05-23

PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES

#2368
20190152989
2019-05-23

ULK1 inhibitors and methods using same

#2369
20190152988
2019-05-23

ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2

#2370
20190152943
2019-05-23

Tetrahydroindazoles and medical uses thereof

#2371
20190152917
2019-05-23

ABHD6 and dual ABHD6/MGL inhibitors and their uses

#2372
20190152912
2019-05-23

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B

#2373
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

#2374
20190144434
2019-05-16

Halogenated quinazolin-THF-amines as PDE1 inhibitors

#2375
20190144432
2019-05-16

Metallo-beta-lactamase inhibitors

#2376
20190144428
2019-05-16

Bicyclic proline compounds

#2377
20190144426
2019-05-16

Quinazolines as potassium ion channel inhibitors

#2378
20190144396
2019-05-16

9-MEMBERED FUSED RING DERIVATIVE

#2379
20190144382
2019-05-16

MEK Inhibitors and Methods of Their Use

#2380
20190142802
2019-05-16

Benzopyrazole compounds and analogues thereof

#2381
20190135825
2019-05-09

Quinazoline and indole compounds to treat medical disorders

#2382
20190135819
2019-05-09

CARM1 inhibitors and uses thereof

#2383
20190135792
2019-05-09

Crystalline form of compound suppressing protein kinase activity, and application thereof

#2384
20190135791
2019-05-09

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#2385
20190135790
2019-05-09

Diaminopyrimidine benzenesulfone derivatives and uses thereof

#2386
20190135789
2019-05-09

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

#2387
20190135765
2019-05-09

Substituted pyrimidine-4-carboxylic acids having anticancer activity

#2388
20190135752
2019-05-09

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#2389
20190135746
2019-05-09

Indoline derivatives and method for using and producing the same

#2390
20190135745
2019-05-09

Immunomodulator compounds

#2391
20190135718
2019-05-09

SMALL MOLECULE INHIBITORS OF NECROPTOSIS

#2392
20190134035
2019-05-09

Quinazoline compounds

#2393
20190134022
2019-05-09

MODULATORS OF CELLULAR ADHESION

#2394
20190133128
2019-05-09

Fungicidal pyridazinones

#2395
20190131543
2019-05-02

Compound for organic electronic element, organic electronic element using same, and electronic device thereof

#2396
20190127445
2019-05-02

Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins

#2397
20190127365
2019-05-02

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#2398
20190127364
2019-05-02

Pyrimidine compound as JAK kinase inhibitor

#2399
20190127360
2019-05-02

Compounds for modulating aquaporins

#2400
20190127349
2019-05-02

Pyridazinone-based broad spectrum anti-influenza inhibitors